Clinical Trials Related to Cyclophosphamide

Related studies linked through entity extraction aliases.

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Status: COMPLETED
Phase: PHASE1/PHASE2

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma

Status: COMPLETED
Phase: PHASE2

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Status: COMPLETED
Phase: PHASE1/PHASE2

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE2

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Status: COMPLETED
Phase: PHASE1

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Status: COMPLETED
Phase: PHASE3

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Status: COMPLETED
Phase: PHASE2

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Status: COMPLETED
Phase: PHASE2

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Status: COMPLETED
Phase: PHASE3

Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients

Status: COMPLETED
Phase: PHASE1/PHASE2

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

Status: TERMINATED
Phase: PHASE3

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

Status: COMPLETED
Phase: PHASE1

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Status: UNKNOWN
Phase: PHASE1

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

Status: COMPLETED
Phase: PHASE2

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE2

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Status: COMPLETED
Phase: PHASE2

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Status: COMPLETED
Phase: PHASE3

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

Status: COMPLETED
Phase: PHASE2

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2